Eye care delivery company spun off from parent; RNAi lawsuit thrown out;

> U.K. drug delivery specialist Q Chop spun off a new eye company called OpsiRx Pharmaceuticals, focused on the delivery of long-lasting products administered directly to the eye using minimally invasive needles. Release

> An intellectual property lawsuit related to the discovery of RNA interference brought against Carnegie Institution of Washington by a UMass researcher was thrown out of a U.S. District Court on a technicality. More (sub. req.)

> Liquidia Technologies formed a new oral health company, Lq3 Pharmaceuticals. The new Morrisville, NC-based company will use Liquidia's Particle Replication in Non-Wetting Templates nanoparticle development platform. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.